Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 10 studies | 31% ± 10% | |
| endothelial cell of vascular tree | 7 studies | 23% ± 7% | |
| epithelial cell | 5 studies | 38% ± 13% | |
| fibroblast | 5 studies | 23% ± 9% | |
| keratinocyte | 3 studies | 39% ± 12% | |
| secretory cell | 3 studies | 37% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| prostate | 3 studies | 32% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 85% | 3162.52 | 1544 / 1809 | 80% | 55.49 | 376 / 472 |
| esophagus | 65% | 1246.81 | 937 / 1445 | 96% | 126.15 | 175 / 183 |
| lung | 84% | 1121.24 | 485 / 578 | 72% | 39.68 | 834 / 1155 |
| stomach | 60% | 1067.48 | 215 / 359 | 84% | 31.68 | 241 / 286 |
| bladder | 48% | 749.24 | 10 / 21 | 84% | 52.50 | 423 / 504 |
| intestine | 38% | 415.93 | 369 / 966 | 84% | 40.30 | 443 / 527 |
| uterus | 21% | 111.96 | 35 / 170 | 80% | 60.04 | 365 / 459 |
| ureter | 0% | 0 | 0 / 0 | 100% | 133.70 | 1 / 1 |
| thymus | 58% | 364.74 | 380 / 653 | 40% | 11.62 | 245 / 605 |
| adrenal gland | 79% | 643.66 | 204 / 258 | 19% | 7.26 | 43 / 230 |
| pancreas | 9% | 29.57 | 31 / 328 | 88% | 48.18 | 157 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 60.48 | 42 / 45 |
| breast | 72% | 687.61 | 329 / 459 | 19% | 5.64 | 214 / 1118 |
| adipose | 85% | 2049.04 | 1021 / 1204 | 0% | 0 | 0 / 0 |
| kidney | 39% | 421.60 | 35 / 89 | 39% | 11.26 | 348 / 901 |
| blood vessel | 74% | 707.08 | 994 / 1335 | 0% | 0 | 0 / 0 |
| prostate | 49% | 419.76 | 119 / 245 | 19% | 5.53 | 97 / 502 |
| heart | 49% | 482.01 | 426 / 861 | 0% | 0 | 0 / 0 |
| ovary | 17% | 78.22 | 31 / 180 | 29% | 4.99 | 123 / 430 |
| brain | 16% | 87.89 | 411 / 2642 | 29% | 7.30 | 202 / 705 |
| peripheral blood | 41% | 174.59 | 378 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 30% | 5.18 | 24 / 80 |
| muscle | 25% | 119.83 | 200 / 803 | 0% | 0 | 0 / 0 |
| liver | 15% | 142.73 | 35 / 226 | 8% | 4.14 | 31 / 406 |
| spleen | 17% | 66.27 | 40 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 1.05 | 1 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0042542 | Biological process | response to hydrogen peroxide |
| GO_0019221 | Biological process | cytokine-mediated signaling pathway |
| GO_0002224 | Biological process | toll-like receptor signaling pathway |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0006954 | Biological process | inflammatory response |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0007612 | Biological process | learning |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0009615 | Biological process | response to virus |
| GO_0006935 | Biological process | chemotaxis |
| GO_0006968 | Biological process | cellular defense response |
| GO_0007565 | Biological process | female pregnancy |
| GO_0051591 | Biological process | response to cAMP |
| GO_0060674 | Biological process | placenta blood vessel development |
| GO_2000144 | Biological process | positive regulation of DNA-templated transcription initiation |
| GO_1902895 | Biological process | positive regulation of miRNA transcription |
| GO_0009629 | Biological process | response to gravity |
| GO_0007296 | Biological process | vitellogenesis |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0010467 | Biological process | gene expression |
| GO_0009612 | Biological process | response to mechanical stimulus |
| GO_0009410 | Biological process | response to xenobiotic stimulus |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_0009611 | Biological process | response to wounding |
| GO_0051412 | Biological process | response to corticosterone |
| GO_0032570 | Biological process | response to progesterone |
| GO_0140467 | Biological process | integrated stress response signaling |
| GO_0045787 | Biological process | positive regulation of cell cycle |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0042734 | Cellular component | presynaptic membrane |
| GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_1990841 | Molecular function | promoter-specific chromatin binding |
| GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
| GO_0003700 | Molecular function | DNA-binding transcription factor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | FOSL1 |
| Protein name | FOS-like antigen 1 isoform 1 FOS like 1, AP-1 transcription factor subunit Fos-related antigen 1 (FRA-1) FOS like 1, AP-1 transcription factor subunit (FOS-like antigen 1 isoform 2) |
| Synonyms | FRA1 |
| Description | |
| Accessions | E9PKL5 ENST00000532401.1 ENST00000312562.7 [P15407-1] E9PPX2 E9PQT6 A0A0S2Z595 ENST00000448083.6 [P15407-2] P15407 ENST00000531493.5 ENST00000534222.1 |
